Development of an original algorithm to characterize serological antibody response that improve infectious diseases surveillance
RAZAFIMAHATRATRA, S. L.; RASOLOHARIMANANA, L. T.; ANDRIAMARO, T. M.; RANAIVOMANANA, P.; SCHOENHALS, M.
Show abstract
Interpreting serological data remains challenging, particularly in low-prevalence or cross-reactive contexts, where antibody responses often show substantial overlap between exposed and unexposed individuals and may depart from normal distributional assumptions. Conventional cutoff-based approaches often yield inconsistent or biased estimates of seroprevalence. Here, we present a decisional framework based on finite mixture models (FMMs) that enhances the robustness and interpretability of serological analyses. Beyond simply applying mixture models, our framework integrates multiple methodological innovations : (i) systematic comparison of Gaussian and skew-normal mixture models to accommodate asymmetric antibody distributions; (ii) rigorous model selection using the Cramer-von Mises test (p > 0.01) combined with a parsimonious score (APS) to prioritize models with well-separated clusters; and (iii) hierarchical clustering of posterior probabilities to collapse latent components into biologically meaningful seronegative and seropositive groups. Applied to chikungunya virus (CHIKV) data from Bangladesh, the framework produced prevalence estimates consistent with ROC-based methods while probabilistically identifying borderline cases. Validation on SARS-CoV-2 and dengue datasets further demonstrated its generalizability: for SARS-CoV-2, the approach identified up to five latent clusters with high sensitivity (up to 100%) and specificity (up to 100%), enabling discrimination by disease severity. For dengue, it revealed interpretable subgrouping consistent with background exposure and subclinical infection, despite limited confirmed cases. By integrating distributional flexibility, robust goodness-of-fit testing, and biologically guided cluster consolidation, this decisional FMM framework provides a reproducible and scalable method for serological interpretation across pathogens and epidemiological settings, addressing key limitations of threshold-based classification.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Predictive values, uncertainty, and interpretation of serology tests for the novel coronavirus 92%
- Predicting dengue importation into Europe, using machine learning and model-agnostic methods. 92%
- Evidence-based pandemic preparedness: an infrastructure for population-scale genome-based based testing for COVID-19 91%
Similar papers in this journal
- Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and reversion by time since infection, test, age and disease severity. 93%
- Assessing generalizability of a dengue classifier across multiple datasets 92%
- A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects 92%
Similar papers in this journal
- Performance of Existing and Novel Symptom- and Antigen Testing-Based COVID-19 Case Definitions in a Community Setting 91%
- Optimizing the sensitivity of detection of respiratory syncytial virus infections in longitudinal studies using the combination of weekly sample testing and biannual serology 90%
- Using LASSO regression to estimate the population-level impact of pneumococcal conjugate vaccines 90%
Similar papers in this journal
- Estimation of the infection attack rate of mumps in an outbreak among college students using paired serology 92%
- Modelling COVID-19 in the North American region with a metapopulation network and Kalman filter 90%
- Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number 90%
Similar papers in this journal
- A method to reduce ELISA serial dilution assay workload applied to SARS-CoV-2 and seasonal HCoVs 91%
- The evolutionary landscape of SARS-CoV-2 variant B.1.1.519 and its clinical impact in Mexico City 90%
- Estimating the effectiveness of shielding during pregnancy against SARS-CoV-2 in New York City during the first year of the COVID-19 pandemic 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.